Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Celerion Announces Expanded State-of-the-Art ADME Suite

Published: Friday, May 18, 2012
Last Updated: Friday, May 18, 2012
Bookmark and Share
The state-of-the-art ADME Suite benefits from on-site bioanalytical services and Phase I clinical facilities to offer clients a one stop solution.

Celerion announced that it has expanded its ADME (Absorption, Distribution, Metabolism and Excretion) Suite in Lincoln, Nebraska USA. Celerion has invested in new state-of-the-art equipment and laboratory space to perform on-site scintillation counting allowing for radioactivity recovery results to be delivered in real-time. This service ensures high total recovery of radioactive dose while providing for efficient clinical study conduct.

The newly expanded ADME Suite adds to Celerion's capabilities to manage all aspects of human radiolabeled ADME studies from synthesis and formulation of an appropriate radiolabeled drug through dosimetry assessment and clinical conduct to final isolation, identification and quantification of metabolites in the samples collected. Radiolabel dosage forms suitable for administration to humans can be readily prepared at Celerion's purpose-built pharmacy clean room at the Lincoln facility. Considering that the Lincoln clinic can also conduct micro-radiotracer studies, Celerion is one of a few organizations globally capable of conducting specialized human ADME studies to regulatory standards.

"The enhancement in our facility was driven by client needs, including a growing interest in conducting these critical studies earlier in a drug's development. This is a response to regulatory guidances concerning knowledge of human metabolism and metabolites during safety assessment," said Raymond Farmen, Vice President, Global Bioanalytical Services. "The on-site bioanalytical and Phase I clinical facilities in Lincoln offer seamless integration of services and data. For bioanalytical analyses, the ADME suite interfaces with Celerion's global electronic laboratory notebook system thereby increasing data compliance."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Celerion Opens Operations in South Korea

Friday, March 07, 2014
Celerion Appoints Executive Director, Applied Translational Medicine
Dr. Bruce Morimoto will have responsibility for developing and implementing strategies for patient populations in early clinical research and clinical pharmacology studies.
Tuesday, June 04, 2013
Celerion Appoints Dr Raymond Farmen as Vice President of Global Bioanalytical Services
Dr Farmen will have responsibility for the company’s bioanalytical operations in Zurich, Switzerland and Lincoln, Nebraska USA.
Friday, July 08, 2011
Celerion Receives ANVISA Certification
Brazilian Regulatory Agency approves Celerion facilities in both North America and Europe to conduct clinical research and bioanalytical services.
Friday, June 24, 2011
Celerion Recognized as Member of the UK Respiratory Therapeutic Capability Cluster
Celerion will work with key decision makers and thought leaders in the UK to develop and execute Phase I and IIa studies with targeted patient populations.
Friday, April 08, 2011
Scientific News
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
Arms Race with a Superbug
Scientists have discovered that increased risk of superbug infection can be directly casued by immune system response to invading bacteria.
Genes Essential to Life Discovered
Genes critical for life are discovered in humans and mice as part of large-scale phenotyping study.
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Manipulation of Liquid Crystals Could Help Control Drug-Delivery Process
Computer modeling, real-world testing yields new method.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!